About David Lockhart
David Lockhart is an executive officer at Recode Therapeutics.
David Lockhart first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name David Lockhart in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Lockhart works with at each company, as listed on that company's latest Form D.
Recode Therapeutics, Inc. · Form D, Oct 23, 2025
RH
Rana Al-Hallaq
Director
PM
Patricia Millican
Director
SS
Shehnaaz Suliman
Executive officer and director
EH
Edward Hurwitz
Director
AC
Alan Colowick
Director
DM
Dean Mitchell
Director
BZ
Basheer Zada
Director
IP
Inai Park
Director
HK
Helen Kim
Director
PT
Peter Thompson
Director
Rakhshita Dhar
Director